Blood Test Could Revolutionize Multiple Myeloma Diagnosis and Monitoring
Multiple myeloma, a type of bone marrow cancer, can be challenging to diagnose and monitor due to the need for painful biopsies and limited testing options. Researchers at Dana-Farber Cancer Institute have developed a blood test called SWIFT-seq that could transform diagnosis and monitoring by providing a non-invasive alternative to traditional methods. The new test … Read more